Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells

Nutrition and Cancer

Volumn 60, Issue SUPPL. 1, 2008, Pages 51-60

  Stan, Silvia D ^a   Zeng, Yan ^a   Singh, Shivendra V ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHASE PROMOTING COMPLEX; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 1; HISTONE H3; PROTEIN CDC25B; PROTEIN CDC25C; SERINE; UNCLASSIFIED DRUG; WITHAFERIN A;

AYURVEDA; BREAST CANCER; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BREAST NEOPLASMS; CDC25 PHOSPHATASES; CELL DIVISION; CELL LINE, TUMOR; ERGOSTEROL; FEMALE; G2 PHASE; HISTONES; HUMANS; MEDICINE, AYURVEDIC; MITOSIS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES;

WITHANIA SOMNIFERA;

EID: 55949092309     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580802381477     Document Type: Conference Paper

References (40)

1. Kelsey JL, Gammon MD, and John EM: Reproductive factors and breast cancer. Epidemiol Rev 15, 36-47, 1993.
2. Hulka BS and Stark AT: Breast cancer: cause and prevention. Lancet 346, 883-887, 1995.
3. Kelsey JL and Bernstein L: Epidemiology and prevention of breast cancer. Annu Rev Public Health 17, 47-67, 1996.
4. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, et al.: Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 90, 1371-1388, 1998.
5. Cuzick J, Forbes J, Edwards R, Baum M, Cawthorn S, et al.: First results from the International Breast Cancer Intervention study (IBIS-I): a randomized prevention trial. Lancet 360, 817-824, 2002.
6. Newman DJ, Cragg CM, and Snader KM: Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66, 1022-1037, 2003.
7. Agarwal R, Diwanay S, Patki P, and Patwardhan B: Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation. J Ethnopharmacol 67, 27-35, 1999.
8. Gupta SK, Mohanty I, Talwar KK, Dinda A, Joshi S, et al.: Cardioprotection from ischemia reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol Cell Biochem 260, 39-47, 2004.
9. Ahmad M, Saleem S, Ahmad AS, Ansari MA, Yousuf S, et al.: Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol 24, 137-147, 2005.
10. Owais M, Sharad KS, Shehbaz A, and Saleemuddin M: Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine 12, 229-235, 2005.
11. Rasool M and Varalakshmi P: Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study. Vascul Pharmacol 44, 406-410, 2006.
12. Mishra LC, Singh BB, and Dagenais S: Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 5, 334-346, 2000.
13. Devi PU, Akagi K, Ostapenko V, Tanaka Y, and Sugahara T: Withaferin A: a new radiosensitizer from the Indian medicinal plant Withania somnifera. Int J Radiat Biol 69, 193-197, 1996.
14. Devi PU, Kamath R, and Rao BS: Radiosensitization of a mouse melanoma by withaferin A: in vivo studies. Indian J Exp Biol 38, 432-437, 2000.
15. Devi PU, Sharada AC, and Solomon FE: In vivo growth inhibitory and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma. Cancer Lett 95, 189-193, 1995.
16. Devi PU, Sharada AC, Solomon FE, and Kamath MS: In vivo growth inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor sarcoma 180. Ind J Exp Biol 30, 169-172, 1992.
17. Ichikawa H, Takada Y, Shishodia S, Jayaprakasam B, Nair MG, et al.: Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression. Mol Cancer Ther 5, 1434-1445, 2006.
18. Kaileh M, Vanden Berghe W, Heyerick A, Horion J, Piette J, et al.: Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem 282, 4253-4264, 2007.
19. Singh D, Aggarwal A, Maura R, and Naik S: Withania somnifera inhibits NF-κB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells. Phytother Res 21, 905-913, 2007.
20. Mohan R, Hammers HJ, Bargagna-Mohan P, Zhan XH, Herbstritt CJ, et al.: Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7, 115-122, 2004.
21. Falsey RR, Marron MT, Gunaherath GM, Shirahatti N, Mahadevan D, et al.: Actin microfilament aggregation induced by withaferin A ismediated by annexin II. Nat Chem Biol 1, 33-38, 2006.
22. Yang H, Shi G, and Dou QP: The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry." Mol Pharmacol 71, 426-437, 2007.
23. Srinivasan S, Ranga R, Burikhanov R, Han S, and Chendil D: Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res 67, 246-253, 2007.
24. Malik F, Kumar A, Bhushan S, Khan S, Bhatia A, et al.: Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 12, 2115-2133, 2007.
25. Stan S, Hahm E, Warin R, and Singh SV: Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res 68, 7661-7669, 2008.
26. Xiao D, Vogel V, and Singh SV: Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak. Mol Cancer Ther 5, 2931-2945, 2006.
27. 2/M arrest and inducing apoptosis. Carcinogenesis 24, 891-897, 2003.
28. Kim YA, Xiao D, Xiao H, Powolny AA, Lew KL, et al.: Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak. Mol Cancer Ther 6, 1599-1609, 2007.
29. Savitsky PA and Finkel T: Redox regulation of Cdc25C. J Biol Chem 277, 20535-20540, 2002.
30. Herman-Antosiewicz A and Singh SV: Checkpoint kinase 1 regulates diallyl trisulfide-induced mitotic arrest in human prostate cancer cells. J Biol Chem 280, 28519-28528, 2005.
31. Hartwell LH and Kastan MB: Cell cycle control and cancer. Science 266, 1821-1828, 1994.
32. Draetta G and Eckstein J: Cdc25 protein phosphatase in cell proliferation. Biochim Biophys Acta 1322, M53-M63, 1997.
33. Pines J and Hunter T: Human cyclins A and B1 are differentially located in the cell and undergo cell cycle dependent nuclear transport. J Cell Biol 115, 1-17, 1991.
34. Widrow RJ, Rabinovitch PS, Cho K, and Laird CD: Separation of cells at different times within G2 and mitosis by cyclin B1 flow cytometry. Cytometry 27, 250-254, 1997.
35. Hendzel MJ, Wei Y, Mancini MA, Van Hooser A, Ranalli T, et al.: Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348-360, 1997.
36. Sudakin V, Ganoth D, Dahan A, Heller H, Hershko J, et al.: The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol Biol Cell 6, 185-197, 1995.
37. Peters JM: The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol Cell 9, 931-943, 2002.
38. Taylor WR and Stark GR: Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815, 2001.
39. Cohen-Fix O, Peters JM, Kirschner MW, and Koshland D: Anaphase initiation in Saccharomyces cerevisiae is controlled by the APC-dependent degradation of the anaphase inhibitor Pds1p. Genes Dev 10, 3081-3093, 1996.
40. Yamamoto A, Guacci V, andKoshland D: Pds1p, an inhibitor of anaphase in budding yeast, plays a critical role in the APC and checkpoint pathway(s). J Cell Biol 133, 99-110, 1996.